Neuren Pharmaceuticals | NEU - Los Gastos De Explotación

Precio De Mercado
12.33
Cambio Diario
0.15 1.23%
Mensual
3.35%
Anual
12.19%
Q2 Expectativa
12.10




Los Gastos De Explotación Cambio Fecha
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Avita Medical AUD 28.02M 1.55M 2025-12
Clinuvel Pharmaceuticals AUD 23.42M 6.49M 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Genetic Signatures AUD 17.52M 9.22M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organon & Co USD 906M 362M 2025-09
Paradigm Biopharmaceuticals AUD 21.85M 13.36M 2025-12
PYC Therapeutics AUD 33.63M 14.33M 2025-12
Starpharma Holdings AUD 11.7M 7.69M 2025-12
Tectonic Therapeutic USD 21.52M 374K 2025-12
Telix Pharmaceuticals AUD 405.4M 26.29M 2025-12
Viatris USD 3.86B 335.7M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12